Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells in vitro
References (34)
- et al.
Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
J. Biol. Chem.
(1994) Bifunctional role of glycosphingolipids
J. Biol. Chem.
(1990)- et al.
Cell surface gangliosides are involved in the control of glioma cell invasion in vitro
Neurosci. Lett.
(1994) - et al.
Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis
Exp. Cell. Res.
(1993) - et al.
Growth factors and gangliosides stimulate laminin production by human glioma cells in vitro
Neurosci. Lett.
(1995) - et al.
Tumours of central neuroepithelial origin
- et al.
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
Nature
(1992) - et al.
Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor
- et al.
Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms
Mod. Pathol.
(1992) - et al.
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
Nature
(1993)
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Nature
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta)
Growth Factors
Control of human glioma cell growth, migration, and invasion in vitro by transforming growth factor-beta 1
Br. J. Cancer
Gangliosides modulate proliferation, migration and invasion of human brain tumour cells in vitro
Mol. Chem. Neuropathol.
Interaction of gangliosides with fibronectin in the mobilization of capillary endothelium. Possible influence on the growth of metastasis
Invasion Metastasis
Interrelationship between differentiation and malignancy-associated properties in glioma
Br. J. Cancer
Cited by (110)
Updates on sphingolipids: Spotlight on retinopathy
2021, Biomedicine and PharmacotherapyCitation Excerpt :Pericyte loss is a hallmark of the initiation of diabetic retinopathy. Pericyte growth inhibition and pericyte dropout, activation of microglia and production of nitric oxide synthase, TNF-α, IL-1β, and VEGF have all been reported in the literature as consequences of altered glycosphingolipid metabolism [107–112]. Inhibition of Cer formation by the use of an ASMase inhibitor, desipramine, has been shown to partially protect pericytes from apoptosis in bovine retinal pericyte cultures [113].
Ganglioside GD3 synthase (GD3S), a novel cancer drug target
2018, Acta Pharmaceutica Sinica BRecent advances in the treatment of glioblastoma multiforme by inhibiting angiogenesis and using nanocarrier systems
2017, Journal of the Taiwan Institute of Chemical EngineersCitation Excerpt :These functions suggest that TGF-β and its receptor are strongly expressed on malignant gliomas, especially in the necrosis and angiogenetic zone [83–91]. Further, as evidence that TGF-β1 acts as an indirect angiogenic factor, TGF-β1 stimulated VEGF expression in mouse embryo fibroblasts [88]. Hence, clinical practice requires a potential strategy to inhibit TGF-β in the treatment of GBM [86].
Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: How to break a vicious cycle
2014, Biochimica et Biophysica Acta - Reviews on CancerAntibody-based immunotherapy for malignant glioma
2014, Seminars in OncologyCitation Excerpt :To this end, TGF-β has surfaced as a promising target for mAb blockade. TGF-β, secreted by glioma cells and microglia, promotes tumor growth via enhancing tumor cell migration and angiogenesis.115,116 TGF-β furthermore contributes to the immunosuppressive tumor microenvironment by inducing a TReg phenotype in naïve CD4+ cells117–119 and suppresses cytotoxic immune responses.82,120,121